Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Chemical Allergen [EPC]
Chromic Sulfate Pentadecahydrate is a standardized chemical allergen used primarily in epicutaneous patch testing to diagnose allergic contact dermatitis related to chromium exposure.
Name
Chromic Sulfate Pentadecahydrate
Raw Name
CHROMIC SULFATE PENTADECAHYDRATE
Category
Standardized Chemical Allergen [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Chromic Sulfate Pentadecahydrate
Chromic Sulfate Pentadecahydrate is a standardized chemical allergen used primarily in epicutaneous patch testing to diagnose allergic contact dermatitis related to chromium exposure.
Detailed information about Chromic Sulfate Pentadecahydrate
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Chromic Sulfate Pentadecahydrate.
Chromic Sulfate Pentadecahydrate (chemical formula: Cr2(SO4)3·15H2O) is a specialized diagnostic agent classified as a Standardized Chemical Allergen [EPC]. In the realm of clinical dermatology and immunology, it serves as a critical tool for identifying sensitization to chromium compounds, which are ubiquitous in industrial and consumer environments. This substance belongs to a class of diagnostic haptens (small molecules that elicit an immune response only when attached to a large carrier such as a protein).
Chromic Sulfate Pentadecahydrate is most commonly encountered by patients as a component of the T.R.U.E. TEST (Thin-layer Rapid Use Epicutaneous Test), an FDA-approved patch testing system. The FDA first approved standardized patch testing panels containing chromium salts in the mid-1990s to provide a reliable, reproducible method for diagnosing Allergic Contact Dermatitis (ACD). Unlike therapeutic medications designed to treat a disease, this agent is used exclusively for the elicitation of a controlled, localized allergic reaction under medical supervision to confirm a patient's sensitivity.
Chromium is a naturally occurring element, but its industrial applications—ranging from leather tanning and cement production to the manufacturing of stainless steel and pigments—make it a frequent cause of occupational skin disease. Chromic Sulfate Pentadecahydrate specifically represents the trivalent state of chromium [Cr(III)], which is the form that ultimately binds to skin proteins to trigger an immune response.
To understand how Chromic Sulfate Pentadecahydrate works, one must understand the pathophysiology of Type IV delayed-type hypersensitivity reactions. This is a T-cell mediated immune response rather than an antibody-mediated one (like the immediate reactions seen with hay fever or bee stings). When the patch containing the allergen is applied to the skin, the chromium ions must penetrate the outer layer of the skin, the stratum corneum.
Once inside the epidermis, the chromium ions (haptens) are too small to be recognized by the immune system on their own. They must undergo 'haptenization,' a process where they chemically bind to endogenous skin proteins (carrier proteins). This hapten-protein complex is then captured by Langerhans cells (specialized antigen-presenting cells in the skin). The Langerhans cells process the complex and migrate to local lymph nodes, where they present the antigen to naive T-lymphocytes. In a sensitized individual—someone whose immune system has been 'primed' by previous exposure to chromium—these T-cells recognize the antigen, proliferate, and travel back to the site of the patch test.
At the test site, these activated T-cells release pro-inflammatory cytokines (such as interferon-gamma and interleukin-2), which recruit other inflammatory cells. This process results in the characteristic redness, swelling, and itching of a positive patch test result. Because this complex cellular recruitment takes time, the reaction typically peaks between 48 and 96 hours after application, which is why patch tests are read several days after the initial application.
As a topically applied diagnostic allergen intended for localized reaction, the pharmacokinetic profile of Chromic Sulfate Pentadecahydrate differs significantly from systemic drugs.
The primary, FDA-approved indication for Chromic Sulfate Pentadecahydrate is as a diagnostic aid in the identification of allergic contact dermatitis in patients 6 years of age and older. It is specifically used to detect sensitivity to chromium.
Common scenarios for its use include:
Chromic Sulfate Pentadecahydrate is not available as a standalone prescription for patient use. It is exclusively available in standardized diagnostic formats:
> Important: Only your healthcare provider can determine if Chromic Sulfate Pentadecahydrate is right for your specific condition. It is a diagnostic tool, not a treatment.
In the context of the T.R.U.E. TEST, the dosage of Chromic Sulfate Pentadecahydrate is pre-calibrated and standardized. The patch contains approximately 0.19 mg/cm² of the active ingredient. For adults, a single patch is applied to healthy, hairless skin, usually on the upper back. The test is not 'dosed' in the traditional sense of milligrams per kilogram, but rather by the surface area of exposure provided by the standardized patch system.
Chromic Sulfate Pentadecahydrate is FDA-approved for use in children as young as 6 years of age. The dosage used in pediatric patients is the same as that used in adults, utilizing the same standardized patch system. Clinical studies have shown that the standardized dose is safe and effective for identifying chromium sensitivity in the pediatric population, provided the child's back is large enough to accommodate the test panels without overlapping.
No dosage adjustments are required for patients with renal impairment. Because the systemic absorption of chromium from the patch test is negligible, the presence of kidney disease does not alter the safety or efficacy of the diagnostic procedure. However, the clinician should be aware of any systemic inflammatory conditions that might affect skin reactivity.
No dosage adjustments are necessary for patients with hepatic (liver) impairment. The metabolism of this agent is localized to the skin's immunological processing and does not rely on hepatic enzymes or biliary excretion.
While no specific dose adjustment is needed for the elderly, healthcare providers may need to exercise caution when interpreting results. Older skin may have reduced reactivity (immunosenescence) or may be more prone to 'false negative' results if the skin is extremely thin or dry. Conversely, fragile skin in the elderly may be more susceptible to irritant reactions from the adhesive tape used to secure the patches.
This agent is applied only by a healthcare professional (usually a dermatologist or allergist). The procedure typically follows these steps:
Since this is a diagnostic procedure performed in a clinic, 'missing a dose' refers to the patch being accidentally removed or falling off before the 48-hour mark. If the patch is removed early, the test may be inconclusive or result in a false negative. If a patch becomes loose, the patient should try to secure the edges with hypoallergenic tape and contact their doctor immediately. If the entire panel falls off, the test may need to be repeated at a later date on a different area of skin.
Systemic overdose is virtually impossible with Chromic Sulfate Pentadecahydrate patch testing due to the low concentration and localized application. However, a 'local overdose' or hyper-reactivity can occur in highly sensitive individuals. This manifests as a severe local reaction (blistering, intense swelling, and pain). In such cases, the clinician will remove the patch immediately and may apply a topical corticosteroid to the site to dampen the immune response.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or attempt to perform patch testing without medical guidance.
Because Chromic Sulfate Pentadecahydrate is designed to provoke an immune response in sensitive individuals, 'side effects' at the site of application are expected and are, in fact, the goal of the test.
> Warning: Stop taking Chromic Sulfate Pentadecahydrate and call your doctor immediately if you experience any of these.
While extremely rare for a diagnostic patch test, systemic reactions can occur.
No FDA black box warnings have been issued for Chromic Sulfate Pentadecahydrate. It is generally considered a safe diagnostic tool when used according to standardized protocols by trained medical professionals.
Report any unusual symptoms to your healthcare provider. Even if a reaction seems mild, documenting the timing and appearance of the skin is vital for an accurate diagnosis.
Chromic Sulfate Pentadecahydrate is intended only for epicutaneous (on the skin) diagnostic use. It should never be ingested, injected, or applied to mucous membranes (such as the eyes, mouth, or genitals). The accuracy of the test depends heavily on the patient following the instructions to keep the area dry and undisturbed for the duration of the testing period. Patients must inform their doctor of all current medications, as certain drugs can suppress the immune response and lead to false-negative results.
There are currently no FDA black box warnings for Chromic Sulfate Pentadecahydrate. It has a long history of safe use in clinical dermatology when administered by specialists.
There are no specific laboratory tests (like blood counts or liver panels) required for Chromic Sulfate Pentadecahydrate testing. The 'monitoring' is purely clinical. The healthcare provider will monitor the skin site at 48 hours and again at 72-96 hours. In some cases, a delayed reading at 7 days is necessary, as chromium is known to sometimes produce very late reactions.
Chromic Sulfate Pentadecahydrate does not affect the central nervous system. There are no restrictions on driving or operating machinery while the patches are in place, provided the patient can do so without vigorous physical activity that might dislodge the patches.
There is no known direct interaction between alcohol and Chromic Sulfate Pentadecahydrate. However, excessive alcohol consumption can cause vasodilation (opening of blood vessels) and increased skin warmth, which might theoretically increase the discomfort of an itchy patch test site. It is best to consume alcohol only in moderation during the testing period.
In the context of patch testing, 'discontinuation' means the early removal of the patches. This is only done if the patient experiences a severe, intolerable local reaction or signs of a systemic allergy. If the patches are removed early, the diagnostic value of the test is lost. There is no 'withdrawal syndrome' associated with this agent.
> Important: Discuss all your medical conditions with your healthcare provider before starting Chromic Sulfate Pentadecahydrate. Ensure they are aware of any history of severe allergic reactions or current use of steroid medications.
There are no specific 'drug-drug' contraindications in the traditional sense, but the following interfere so significantly with the test that they should be avoided:
Chromic Sulfate Pentadecahydrate does not interfere with standard blood or urine laboratory tests. Its effect is entirely localized to the skin's immunological response at the site of application.
For each major interaction, the mechanism is usually pharmacodynamic—the interfering substance (like a steroid) acts on the same physiological pathway (inflammation/immune response) that the patch test is trying to trigger. This leads to reduced efficacy (a false negative) rather than increased toxicity.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list allows the clinician to schedule the test for a time when the results will be most accurate.
Chromic Sulfate Pentadecahydrate must NEVER be used in the following circumstances:
In these cases, the healthcare provider will perform a careful risk-benefit analysis:
Patients who are allergic to Chromic Sulfate Pentadecahydrate often show cross-sensitivity to other chromium salts, most notably Potassium Dichromate. Potassium dichromate contains hexavalent chromium [Cr(VI)], which is more common in industrial settings (like wet cement). While the pentadecahydrate form is trivalent [Cr(III)], the body's immune system often recognizes the chromium ion regardless of its initial oxidation state once it has bound to skin proteins.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to jewelry, leather, or industrial chemicals, before prescribing or applying Chromic Sulfate Pentadecahydrate.
Chromic Sulfate Pentadecahydrate is classified as Pregnancy Category C (under the older FDA system). There have been no adequate and well-controlled studies in pregnant women. Because the systemic absorption of chromium from a standardized patch is extremely low, the risk to the fetus is considered minimal. However, because patch testing is a diagnostic procedure and not a life-saving treatment, it is standard clinical practice to defer testing until after the patient has given birth. This avoids the need for any medications (like topical steroids) that might be required to treat a strong positive reaction.
It is not known whether the trace amounts of chromium absorbed from a patch test are excreted in human milk. However, given the negligible systemic absorption, it is highly unlikely that a nursing infant would be exposed to any significant amount of the substance. Breastfeeding is generally not considered a contraindication to patch testing, though patients should discuss the timing with their doctor.
As of 2026, Chromic Sulfate Pentadecahydrate is FDA-approved for use in children aged 6 years and older. Clinical trials have demonstrated that the T.R.U.E. TEST is safe and effective in this age group. The main challenge in pediatric use is the physical size of the child's back; the clinician must ensure there is enough surface area to apply the panels securely. Children may also be more prone to dislodging the patches through play, so extra adhesive or 'over-taping' is often required.
In patients over 65, the skin undergoes physiological changes, including thinning of the dermis and a decrease in the number of Langerhans cells. This can lead to less vigorous allergic reactions. A 'weak' positive in an elderly patient might be just as clinically significant as a 'strong' positive in a younger patient. Additionally, elderly patients are more likely to be taking multiple systemic medications (polypharmacy) that could interfere with immune reactivity. Clinicians should carefully review the medication list for any hidden immunosuppressants.
There are no specific restrictions for patients with renal impairment. Trivalent chromium is a trace element normally handled by the kidneys, but the amount used in a patch test is so small that it does not place any burden on renal function. No GFR-based adjustments are necessary.
Liver disease does not affect the safety or the results of a Chromic Sulfate Pentadecahydrate patch test. The diagnostic process is localized to the skin and the lymphatic system, bypassing hepatic metabolism.
> Important: Special populations require individualized medical assessment. Always inform the testing physician if you are pregnant, planning to become pregnant, or have any chronic health conditions.
Chromic Sulfate Pentadecahydrate acts as a hapten. At the molecular level, the trivalent chromium [Cr(III)] ion reacts with the amino acid side chains of skin proteins (primarily lysine and histidine residues) to form a stable conjugate. This conjugate is recognized as 'foreign' by the immune system. The mechanism is a classic Type IV Hypersensitivity, involving the sensitization phase (initial exposure and memory T-cell formation) and the elicitation phase (the patch test itself). The primary 'targets' are the T-cell receptors on CD4+ and CD8+ lymphocytes, which recognize the chromium-protein complex when presented by MHC molecules on Langerhans cells.
The dose-response relationship in patch testing is binary: either the patient is sensitized (positive) or they are not (negative). However, the intensity of the response (1+, 2+, or 3+) can correlate with the degree of clinical sensitivity. The time to onset is delayed, with reactions usually appearing after 48 hours. The duration of the effect (the visible rash) can last from several days to several weeks. Tolerance does not develop with this diagnostic agent; in fact, repeated testing could theoretically increase sensitivity.
| Parameter | Value |
|---|---|
| Bioavailability | Negligible (Systemic) |
| Protein Binding | >90% (Local skin proteins) |
| Half-life | N/A (Localized reaction) |
| Tmax | 48-96 hours (for clinical reaction) |
| Metabolism | None (Inorganic salt) |
| Excretion | Primarily via physical removal of patch |
Chromic Sulfate Pentadecahydrate is a Standardized Chemical Allergen. It is part of the diagnostic category of 'In Vivo Diagnostic Radiopharmaceuticals and Other Agents.' Within dermatology, it is grouped with other metal allergens like Nickel Sulfate and Cobalt Chloride.
Common questions about Chromic Sulfate Pentadecahydrate
Chromic Sulfate Pentadecahydrate is used exclusively as a diagnostic tool to identify if a person has an allergy to chromium. It is applied to the skin as part of a patch test, typically when a doctor suspects Allergic Contact Dermatitis. Common sources of chromium exposure include leather goods, cement, and certain metal alloys. By applying a standardized amount under a patch, doctors can observe if a localized rash develops over several days. This helps confirm whether chromium is the cause of a patient's chronic skin irritation.
The most common side effects are localized to the area where the patch was applied and include itching, redness, and a small raised rash. These symptoms are actually the intended result of the test in individuals who are allergic to chromium. Some patients may also experience irritation from the adhesive tape used to secure the patches. These local reactions typically peak within 3 to 4 days and fade within a week. In rare cases, a small area of skin discoloration may persist for a few weeks after the test is completed.
There is no direct medical contraindication to drinking alcohol while undergoing a patch test with Chromic Sulfate Pentadecahydrate. However, alcohol can cause blood vessels in the skin to dilate, which might make an itchy test site feel more uncomfortable or inflamed. It is generally recommended to consume alcohol only in moderation during the 48 to 96 hours of the testing period. You should also ensure that alcohol consumption does not lead to activities that might cause heavy sweating or the accidental removal of the patches. Always follow any specific lifestyle restrictions provided by your dermatologist.
While there is no evidence that Chromic Sulfate Pentadecahydrate causes birth defects or other pregnancy complications, it is generally not recommended during pregnancy. This is because patch testing is a non-emergency diagnostic procedure that can usually be delayed until after delivery. If a severe allergic reaction occurs during the test, the medications needed to treat it (like strong steroid creams) might not be ideal for use during pregnancy. Most healthcare providers prefer to wait to ensure the safety of both the mother and the developing baby. If you are pregnant, be sure to inform your doctor before the test is scheduled.
Chromic Sulfate Pentadecahydrate works through a delayed-type hypersensitivity reaction, which takes time to develop. The patches must remain on the skin for 48 hours to allow the chromium to penetrate and the immune cells to react. A doctor will usually perform a first reading when the patches are removed at 48 hours, but the 'final' result is often not clear until 72 to 96 hours after the start of the test. In some cases, chromium reactions can be very slow to appear, and a doctor may even request a final check after one week. This timing is essential for distinguishing between a true allergy and a simple skin irritation.
Since Chromic Sulfate Pentadecahydrate is a diagnostic patch and not a daily medication, 'stopping' it simply means removing the patch. If you experience an intense, painful, or blistering reaction, your doctor may decide to remove the patch before the full 48 hours have passed. However, you should never remove the patches yourself unless specifically instructed to do so by your healthcare provider, as this will likely make the test results invalid. There are no withdrawal symptoms or physical dependencies associated with this substance. Once the patch is removed and the area is cleaned, the exposure to the allergen ends immediately.
In the context of patch testing, a 'missed dose' usually means the patch has fallen off or been accidentally removed before the scheduled 48-hour check. If a patch becomes loose, you should try to carefully secure the edges with hypoallergenic tape and notify your doctor's office. If the patch falls off completely, do not try to reapply it yourself, as the timing and placement are critical for an accurate reading. Your doctor will determine if the test can still be read or if it needs to be repeated at a later date. It is vital to keep the test area dry and avoid heavy exercise to prevent this from happening.
No, Chromic Sulfate Pentadecahydrate does not cause weight gain. It is a diagnostic agent applied topically to a very small area of the skin for a short period. The amount of chromium that enters the bloodstream is negligible and has no effect on metabolism, appetite, or fat storage. Any systemic medications you might be taking for your skin condition, such as oral steroids, could potentially affect weight, but the patch test itself is entirely neutral in this regard. If you have concerns about weight changes, you should discuss them with your primary care physician.
Chromic Sulfate Pentadecahydrate can be used while taking most medications, but there are important exceptions. Systemic immunosuppressants and oral corticosteroids (like prednisone) can suppress your immune system's ability to react to the patch, leading to a false-negative result. You should generally be off these medications for several weeks before the test. Topical steroid creams must also not be applied to the back where the patches will be placed. Interestingly, most common antihistamines do not interfere with this specific type of allergy test, but you should still provide your doctor with a full list of everything you are taking.
Chromic Sulfate Pentadecahydrate is not a drug you can buy at a pharmacy, so the concept of 'generic' vs. 'brand name' is slightly different. It is a standardized chemical component used in professional diagnostic kits. The most common brand-name system that includes this ingredient is the T.R.U.E. TEST. While other companies may manufacture chromium patches for allergy testing, these are only sold to and used by licensed healthcare professionals. You cannot purchase these patches for home use, as the application and interpretation require specialized medical training to ensure an accurate diagnosis.